A systematic review on poly(I:C) and poly-ICLC in glioblastoma: adjuvants coordinating the unlocking of immunotherapy

Jorrit De Waele(University of Antwerp), Evelien Smits(University of Antwerp)
Journal of Experimental & Clinical Cancer Research
June 25, 2021
Cited by 107


Related Papers

CD70: An emerging target in cancer immunotherapy
|Pharmacology & Therapeutics|2015|225